IMPACT OF BUSULFAN, ETOPOSIDE AND HIGH-DOSE ARA-C (BEA) CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML

被引：0
|
作者：
Sanz, Jaime [1 ,2 ]
Labopin, Myriam [3 ]
Daskalakis, Michael [4 ]
Broers, A. E. C. [5 ]
Van Gorkom, Gwendolyn [6 ]
Meijer, Ellen [7 ]
Gedde-Dah, Tobias [8 ]
Montoro, Juan [1 ,2 ]
Arcese, William [9 ]
Antonio Perez-Simon, Jose [10 ]
Schaap, N. [11 ]
Maertens, Johan [12 ]
Vrhovac, Radovan [13 ]
Lanza, Francesco [14 ]
Gorin, Norbert Claude [15 ]
Mohty, Mohamad [15 ]
Ciceri, Fabio [16 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
[2] Inst Carlos III, CIBERONC, Madrid, Spain
[3] Hosp St Antoine, EBMT Paris Off, Paris, France
[4] Univ Hosp Bern, Paediat Hematol Oncol, Bern, Switzerland
[5] Erasmus MC, Univ Med Ctr Rotterdam, Inst Canc, Rotterdam, Netherlands
[6] Univ Hosp Maastricht, Maastricht, Netherlands
[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[8] Oslo Univ Hosp, Sect Stem Cell Transplantat, Clin Canc Med, Rikshosp, Oslo, Norway
[9] Tor Vergata Univ Rome, Stem Cell Transplant Unit, Policlin Univ Vergata, Rome, Italy
[10] Hosp Univ Virgen Rocio, Serv Hematol & Hemoterapia, Serv Andaluz Salud, Seville, Spain
[11] Nijmegen Med Ctr, Nijmegen, Netherlands
[12] Univ Hosp Gasthuisberg, Leuven, Belgium
[13] Univ Hosp Ctr Rebro, Zagreb, Croatia
[14] Osped Civile, Unita Operat Ematol, Ravenna, Italy
[15] Sorbonne Univ, Hop St Antoine, INSERM UMRs 938, Paris, France
[16] Ospedale San Raffaele srl, Haematol & BMT, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O054
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] High-dose etoposide in allogeneic stem cell transplantation
    Bruserud, Oystein
    Reikvam, Hakon
    Kittang, Astrid Olsnes
    Ahmed, Aymen Bushra
    Tvedt, Tor Henrik Anderson
    Sjo, Malvin
    Hatfield, Kimberley Joanne
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 765 - 782
  • [32] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [33] HIGH-DOSE ARA-C THERAPY - A REVIEW
    GASSMANN, W
    SCHMITZ, N
    LOFFLER, H
    ONKOLOGIE, 1985, 8 (01): : 8 - &
  • [34] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [35] Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation
    Wadehra, Navin
    Farag, Sherif
    Bolwell, Brian
    Elder, Patrick
    Penza, Sam
    Matt, Kalaycio
    Avalos, Belinda
    Pohlman, Brad
    Marcucci, Guido
    Sobecks, Ronald
    Lin, Thomas
    Andresen, Steven
    Copelan, Edward
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1343 - 1349
  • [36] Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Park, Chan-sik
    Lee, Sang-wook
    Kim, Jeong Hoon
    Ryu, Jin Sook
    Huh, Jooryung
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1657 - 1664
  • [37] Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma
    Jaewon Hyung
    Jung Yong Hong
    Dok Hyun Yoon
    Shin Kim
    Jung Sun Park
    Chan-sik Park
    Sang-wook Lee
    Jeong Hoon Kim
    Jin Sook Ryu
    Jooryung Huh
    Cheolwon Suh
    Annals of Hematology, 2019, 98 : 1657 - 1664
  • [38] High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma
    谷景立
    China Medical Abstracts(Internal Medicine), 2019, 36 (04) : 230 - 231
  • [39] High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.
    Cogle, CR
    Moreb, JS
    Belanger, GL
    Leather, HL
    Boyette, RM
    Finiewicz, K
    Khan, SA
    Reddy, VS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 368B - 368B
  • [40] Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
    Agaliotis, DP
    Ballester, OF
    Mattox, T
    Hiemenz, JW
    Fields, KK
    Zorsky, PE
    Goldstein, SC
    Perkins, JB
    Rosen, RM
    Elfenbein, GJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 292 - 298
12345